health policy

health policy

health policy

Three studies suggest that, although men live shorter lives than women, their health receives little attention in health policies

In general, men’s life expectancy is lower than that of women, and they lose 16 per cent of their healthy life years due to illness or disability. A series of three articles published in The Lancet points out that these differences cannot be explained solely by biological factors, but also by social and economic conditions and other structural factors. Despite this, the articles highlight that men’s health continues to receive scant attention in health policies. The authors warn that this lack of attention leaves room for commercial interests and movements such as the ‘manosphere’ to influence the discourse on men’s health. They therefore call for it to be integrated into public policy, without framing it as an issue that competes with women’s health or with efforts to reduce gender inequalities.
 

0

The Council of Ministers has approved the draft tobacco bill, which extends smoke-free areas and bans smoking by minors

On Tuesday, the Council of Ministers approved the draft bill amending the current Tobacco Act, which was passed in 2005. The bill now begins its passage through Parliament and includes new measures to tackle smoking and regulate tobacco-related products. The text prohibits the consumption of tobacco by minors — in addition to its sale —, extends smoke-free zones to outdoor seating areas and other spaces, and restricts the advertising of tobacco-related products. It also treats e-cigarettes and other devices in the same way as traditional tobacco cigarettes, amongst other measures.

0

Urban forests are essential for climate resilience, biodiversity, and public health

An essay published today in the journal PLOS Climate examines the need for “immediate and sustained” investment to safeguard urban forests. The article reviews the necessary policies, ranging from maintenance and management to legal protections. The authors call on policymakers to “prioritize” these spaces in their strategies to combat climate change, given their positive role in climate resilience, biodiversity, and public health.

0

Policies to promote physical activity fall short

The adoption of policies promoting physical activity has increased over the last two decades, but there is limited evidence that these policies are being implemented, and physical inactivity has remained high during this period, says an article published in Nature Health. The study is based on an analysis of documents from 200 countries and interviews with 46 experts, including one from the ISGlobal research institute in Barcelona.

0

Substituting physicians for nurses in hospital interventions does not affect patient safety, says review

In certain hospital interventions that replace medical doctors with nurses, there is little or no difference in patient mortality and quality of life, according to research that brings together the results of 82 previous studies, and includes data from healthcare personnel from different specialities. "While our findings suggest there is merit in pursuing [nurse-physician substitution] as a solution to shortages and maldistribution of doctors, it is also important to consider the implications of [nurse-physician substitution] on the availability of nurses and future developments in the scope of nursing practice," the authors write in the study, published in the Cochrane Database of Systematic Reviews.

0

A review identifies what most influences polarization on health issues

A study by the University of Cádiz has identified six factors that drive polarization around health-related issues, for example during crises such as the COVID-19 pandemic: political ideology, misinformation, social media dynamics, trust in institutions and professionals, risk perception, and socioeconomic factors. This review, published in Science Advances, brings together the conclusions of 90 previous studies and analyzes how these determinants exacerbate health inequalities and influence compliance with public health measures.

0

Controversy over the Trump administration's proposal of leucovorin as a treatment for autism

At a press conference at the White House on Monday, Donald Trump and health authorities linked the use of paracetamol during pregnancy to cases of autism. They also recommended leucovorin as a treatment for autism. Immediately afterwards, the US Food and Drug Administration (FDA) announced in a press release that it had begun the approval process for calcium leucovorin tablets for patients with cerebral folate deficiency. “People with cerebral folate deficiency have been observed to have developmental delays with autistic characteristics, seizures, and movement and coordination problems,” they said. The update on the use of the drug, discussed by the scientific community, will authorize the treatment of children with autism spectrum disorder.

 

0

What we know about biosimilar medicines

Biosimilars work in a similar way to biologics - which are made from living cells and are very complex and expensive - such as insulin, growth hormone, vaccines and monoclonal cancer antibodies. We explain what savings biosimilars bring to the healthcare system and what the process is to ensure that their quality, efficacy and safety are equivalent to those of the reference medicine.

0